mrna covid

covid pneumonia

severe acute respiratory

syndrome coronavirus sars-cov

inflammatory rheumatic

patients rheumatic

inflammatory syndrome

sars infection

sars cov

International Immunopharmacology

While most patients with coronavirus disease 2019 (COVID-19) present with mild or moderate symptoms, 15% may develop severe pneumonia, 5% develop acute respiratory distress syndrome (ARDS), septic shock, and multiple organ failure. Some patients may also experience arthralgia or arthritis. Cases of reactive arthritis have been reported during or after COVID-19. With the approval of the use of COVID-19 vaccines, the vaccination program was started in our country and is still continuing.Here we present two patients who developed arthritis after COVID-19 vaccination.

Arthritis following COVID-19 vaccination: report of two cases